Transitioning to the "New Normal": What This Means for Oncology Care with Dr. Burt Zweigenhaft, Co-founder of the Association for Value-Based Cancer Care

Dr. Burt Zweigenhaft, Co-founder of the Association for Value-Based Cancer Care, shares his thoughts on the importance of patient-centricity in cancer care, current barriers to value-based care in the US and Canada, innovative cancer therapies, and how COVID-19 has affected oncology care delivery and research.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalDr. Burt Zweigenhaft: https://www.linkedin.com/in/burtzweigenhaft/Association for Value-Based Cancer Care: https://www.valuebasedcancer.com/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital